Navigation Links
On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments
Date:2/19/2008

ANN ARBOR, Mich., Feb. 19 /PRNewswire/ -- Compendia Bioscience, Inc. today announced results of a second productive year, including a renewed and expanding commitment from all major customers and the addition of several "Top 20" oncology drug companies to its customer roster. The new customers and existing customer commitment expansions led to a greater than 300% revenue increase, with similar growth forecasted for 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070213/NYTU093LOGO )

A key factor in Compendia's financial growth in 2007 was the mid-year release of Oncomine(TM) Concepts Edition, a unique analysis approach using drug and pathway signatures to help drug researchers and developers better understand a specific drug's biology and predict tumor populations likely to respond to the drug. Additionally, Compendia significantly expanded the Oncomine gene expression database in 2007 with cell line panels and drug perturbation studies, areas of specific interest for its customers.

"The addition of Oncomine Concepts Edition and targeted expansion of our data collection and curation efforts were key to our sales success last year, and multi-year commitments from customers have positioned us well for 2008 and beyond," said John Freshley, Compendia's Chief Business Officer. "We are particularly proud that we now count 12 of the top 20 oncology companies as our customers and are in active discussions with several more."

In addition, a major product milestone was completed in 2007 with the transition of the free academic offering from the University of Michigan to Compendia. With more than 15,000 user registrations, Oncomine has long been a leading tool for academic and non-profit researchers.

"This was a very significant step for Compendia," commented co-founder and CEO Dan Rhodes. "We have actively developed exciting new features for Oncomi
'/>"/>

SOURCE Compendia Bioscience, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Spherix Reports Second Quarter Earnings
2. Tapestry Reports Second Quarter 2007 Results
3. Callisto Reports on Second-Quarter 2007 Milestones
4. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
11. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)...  Teradata (NYSE: TDC ), the ... company, today announced the newest analytic innovation ... Life Sciences helps organizations integrate and analyze data ... (RED), clinical analysis, Real-World Evidence (RWE), and finance. ... can benefit by bringing safer, more effective treatments ...
(Date:4/20/2015)... , April 20, 2015 Pharmaceutical Research and ... $51.2 billion last year in the research and development ... represents the majority of all biopharmaceutical R&D spending – ... United States . The new R&D numbers, the ... are highlighted in the newly released PhRMA ...
(Date:4/20/2015)... Ill. , April 20, 2015  U.S. pharmacy cost ... expected to drift into the low double-digits by 2016, according ... talent, retirement and health solutions business of Aon plc ... design changes are projected to be 9.5 percent in 2015 ... Aon Hewitt predicts a similar rate of increase ...
Breaking Medicine Technology:Teradata Delivers Big Analytics Innovation for Life Sciences 2Teradata Delivers Big Analytics Innovation for Life Sciences 3Teradata Delivers Big Analytics Innovation for Life Sciences 4PhRMA Member Companies Invested $51.2 Billion in R&D in 2014 2PhRMA Member Companies Invested $51.2 Billion in R&D in 2014 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 2Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 4
... Laboratories, Inc. (OTCBB: UGNE), a leader in ... therapeutics, today announced the Company,s Vice President of ... presenting at IBC,s 4th Annual AsiaTIDES Oligonucleotide and ... Hotel in Tokyo, Japan. The TIDES ...
... DIEGO, Feb. 27, 2012 Optimer Pharmaceuticals, Inc. (NASDAQ: ... and fiscal year 2011 financial results and provide a ... the NASDAQ Global Market closes on March 7th.  The ... at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). ...
Cached Medicine Technology:Unigene to Present at IBC's 4th Annual AsiaTIDES Oligonucleotide and Peptide® Conference 2Unigene to Present at IBC's 4th Annual AsiaTIDES Oligonucleotide and Peptide® Conference 3Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and FY 2011 Financial Results 2
(Date:4/20/2015)... 2015 “Consumers deserve to know that their ... children’s hair will not put their health at risk,” said ... National Alliance for Hispanic Health, the nation’s leading Hispanic health ... not had authority to ensure cosmetic and personal care products ... had authority to get products off the shelves if they ...
(Date:4/20/2015)... April 20, 2015 Goodreads is sponsoring ... Insurance: Why It’s Good for You and Your Company ... Zane Pilzer and Rick Lindquist have released a ... Why It’s Good for You and Your Company. The ... health insurance woes - employer-funded individual health insurance. ...
(Date:4/20/2015)... The normal response from the doctor used to be, ... Especially if the patient sought medical care after the six-hour ... different. So it’s critical the patient’s loved ones or caregiver ... , Not every emergency room physician or neurosurgeon has the ... But, according to Ronald P. Benitez , neurosurgeon and ...
(Date:4/20/2015)... Early registration is open for the 2nd ... at the start line. Returning to James Kealoha Beach ... to 500 participants (actually there’s only 499 spots since Big ... Now thru April 30, the entry fee is only $150 ... 1st, the fee goes up to $200 and $100, respectively. ...
(Date:4/20/2015)... Florida Hospital at Connerton Long Term ... from Select Medical, during the annual ceremony hosted at ... Chief Operating Officer, Debi Martoccio, received the Leadership Award ... of six recipients out of 113 hospitals nationwide. The ... for the contributions to the community as well as ...
Breaking Medicine News(10 mins):Health News:Statement of National Alliance for Hispanic Health on Senate Introduction of Personal Care Products Safety Act 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 3Health News:"What More Can Be Done?” – The Critical Question That Can Save a Stroke Victim 2Health News:"What More Can Be Done?” – The Critical Question That Can Save a Stroke Victim 3Health News:Hilo Triathlon Kicks Up Its Heels A Second Time; Early Bird Registration Available Online Now. 2Health News:Hilo Triathlon Kicks Up Its Heels A Second Time; Early Bird Registration Available Online Now. 3Health News:Florida Hospital at Connerton Long Term Acute Care Earns Awards from Select Medical including the Stu Dinney Humanitarian Award 2Health News:Florida Hospital at Connerton Long Term Acute Care Earns Awards from Select Medical including the Stu Dinney Humanitarian Award 3
... , , RALEIGH ... SNN ; LSE: SN) Biologics & Spine is proceeding to ... of DUROLANE(R) Single Injection, Stabilized Hyaluronic Acid. , , ... and their global commercial partner, Smith & Nephew met today with ...
... , , , NEW YORK, Aug. ... the beauty industry is the naturals and organic market and HBA Global ... has obtained one of its most well-known innovators and activists to deliver ... the Special Events Hall of the Javits Center in New York. ...
... ... , ... 19, 2009 -- As parents across the country check off school items from their shopping ... season -- foot-friendly shoes. Whether on the school bus, in the classroom or on the ...
... , , , ELM GROVE, Wis., Aug. ... rgency D e partment Core Measures: A ... Comp i rion Healthcare Solutions to aid Hospital Emergency ... for AMI , CHA and CAP patients. Compliance with JCAHO ...
... Alahari, PhD, Associate Professor of Biochemistry and Molecular Biology at ... first time that a tiny piece of RNA appears to ... cancer and identified a gene that appears to inhibit invasive ... 2009 issue of the Journal of Biological Chemistry . ...
... for hand-held technologies , WEDNESDAY, Aug. 19 (HealthDay News) ... to smudge easily, but scientists say they have a ... of protective coatings, a finding that may lead to ... key to anti-smudge coatings is perfluoro alkyl ether, a ...
Cached Medicine News:Health News:Smith & Nephew Takes Single Injection PMA to Next Stage 2Health News:Smith & Nephew Takes Single Injection PMA to Next Stage 3Health News:Smith & Nephew Takes Single Injection PMA to Next Stage 4Health News:Horst M. Rechelbacher To Deliver HBA Global Expo Keynote Address 2Health News:Horst M. Rechelbacher To Deliver HBA Global Expo Keynote Address 3Health News:Give Shoes the '1,2,3 Test' During Back-To-School Shopping 2Health News:Give Shoes the '1,2,3 Test' During Back-To-School Shopping 3Health News:Compirion Hosts Free Webinar on Achieving JCAHO-Compliant Quality Outcomes 2Health News:Compirion Hosts Free Webinar on Achieving JCAHO-Compliant Quality Outcomes 3Health News:LSUHSC research discovers new targets for treatment of invasive breast cancer 2Health News:A Smudge-Free Smart Phone Screen? 2
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Low-profile, hand-held instrument....
Low-profile, hand-held instrument....
Medicine Products: